REIT - Office
Compare Stocks
2 / 10Stock Comparison
BXP vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
BXP vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities |
| Market Cap | $9.29B | $150.14B |
| Revenue (TTM) | $3.48B | $11.63B |
| Net Income (TTM) | $277M | $1.43B |
| Gross Margin | 60.6% | 39.1% |
| Operating Margin | 42.3% | 4.4% |
| Forward P/E | 35.1x | 78.9x |
| Total Debt | $17.36B | $21.38B |
| Cash & Equiv. | $1.48B | $5.03B |
BXP vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| BXP, Inc. (BXP) | 100 | 68.1 | -31.9% |
| Welltower Inc. (WELL) | 100 | 422.9 | +322.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BXP vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BXP is the clearest fit if your priority is value and dividends.
- Lower P/E (35.1x vs 78.9x)
- 6.9% yield, vs WELL's 1.3%
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 230.2% 10Y total return vs BXP's -27.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs BXP's 2.2% | |
| Value | Lower P/E (35.1x vs 78.9x) | |
| Quality / Margins | 12.3% margin vs BXP's 8.0% | |
| Stability / Safety | Beta 0.13 vs BXP's 0.96, lower leverage | |
| Dividends | 6.9% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +43.9% vs BXP's -4.8% | |
| Efficiency (ROA) | 2.3% ROA vs BXP's 1.1%, ROIC 0.5% vs 6.1% |
BXP vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BXP vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — BXP and WELL each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 3.3x BXP's $3.5B. Profitability is closely matched — net margins range from 12.3% (WELL) to 8.0% (BXP). On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.5B | $11.6B |
| EBITDAEarnings before interest/tax | $2.4B | $2.8B |
| Net IncomeAfter-tax profit | $277M | $1.4B |
| Free Cash FlowCash after capex | $690M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +60.6% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +42.3% | +4.4% |
| Net MarginNet income ÷ Revenue | +8.0% | +12.3% |
| FCF MarginFCF ÷ Revenue | +19.8% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.2% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.1% | +22.5% |
Valuation Metrics
BXP leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 33.6x trailing earnings, BXP trades at a 78% valuation discount to WELL's 154.2x P/E. On an enterprise value basis, BXP's 8.8x EV/EBITDA is more attractive than WELL's 66.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $9.3B | $150.1B |
| Enterprise ValueMkt cap + debt − cash | $25.2B | $166.5B |
| Trailing P/EPrice ÷ TTM EPS | 33.64x | 154.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 35.10x | 78.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.84x | 66.76x |
| Price / SalesMarket cap ÷ Revenue | 2.67x | 14.08x |
| Price / BookPrice ÷ Book value/share | 1.21x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 13.47x | 52.72x |
Profitability & Efficiency
BXP leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BXP delivers a 3.6% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to BXP's 2.26x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs BXP's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +3.6% | +3.5% |
| ROA (TTM)Return on assets | +1.1% | +2.3% |
| ROICReturn on invested capital | +6.1% | +0.5% |
| ROCEReturn on capital employed | +7.8% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 2.26x | 0.49x |
| Net DebtTotal debt minus cash | $15.9B | $16.3B |
| Cash & Equiv.Liquid assets | $1.5B | $5.0B |
| Total DebtShort + long-term debt | $17.4B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | 1.59x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $7,278 for BXP. Over the past 12 months, WELL leads with a +43.9% total return vs BXP's -4.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 41.3% vs BXP's 10.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -12.7% | +15.0% |
| 1-Year ReturnPast 12 months | -4.8% | +43.9% |
| 3-Year ReturnCumulative with dividends | +33.7% | +182.2% |
| 5-Year ReturnCumulative with dividends | -27.2% | +212.6% |
| 10-Year ReturnCumulative with dividends | -27.7% | +230.2% |
| CAGR (3Y)Annualised 3-year return | +10.2% | +41.3% |
Risk & Volatility
WELL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
WELL is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than BXP's 0.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 97.6% from its 52-week high vs BXP's 73.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.96x | 0.13x |
| 52-Week HighHighest price in past year | $79.33 | $219.59 |
| 52-Week LowLowest price in past year | $49.72 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +73.8% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 59.3 | 62.6 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 2.6M |
Analyst Outlook
Evenly matched — BXP and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BXP as "Buy" and WELL as "Buy". Consensus price targets imply 23.2% upside for BXP (target: $72) vs 5.7% for WELL (target: $227). For income investors, BXP offers the higher dividend yield at 6.92% vs WELL's 1.29%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $72.10 | $226.50 |
| # AnalystsCovering analysts | 42 | 34 |
| Dividend YieldAnnual dividend ÷ price | +6.9% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $4.05 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
BXP leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). WELL leads in 2 (Total Returns, Risk & Volatility). 2 tied.
BXP vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BXP or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 2. 2% for BXP, Inc. (BXP). BXP, Inc. (BXP) offers the better valuation at 33. 6x trailing P/E (35. 1x forward), making it the more compelling value choice. Analysts rate BXP, Inc. (BXP) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BXP or WELL?
On trailing P/E, BXP, Inc.
(BXP) is the cheapest at 33. 6x versus Welltower Inc. at 154. 2x. On forward P/E, BXP, Inc. is actually cheaper at 35. 1x.
03Which is the better long-term investment — BXP or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +212. 6%, compared to -27. 2% for BXP, Inc. (BXP). Over 10 years, the gap is even starker: WELL returned +230. 2% versus BXP's -27. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BXP or WELL?
By beta (market sensitivity over 5 years), Welltower Inc.
(WELL) is the lower-risk stock at 0. 13β versus BXP, Inc. 's 0. 96β — meaning BXP is approximately 624% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 2% for BXP, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BXP or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 2. 2% for BXP, Inc. (BXP). On earnings-per-share growth, the picture is similar: BXP, Inc. grew EPS 1833% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BXP or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus 7. 9% for BXP, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BXP leads at 55. 7% versus 3. 3% for WELL. At the gross margin level — before operating expenses — BXP leads at 60. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BXP or WELL more undervalued right now?
On forward earnings alone, BXP, Inc.
(BXP) trades at 35. 1x forward P/E versus 78. 9x for Welltower Inc. — 43. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BXP: 23. 2% to $72. 10.
08Which pays a better dividend — BXP or WELL?
All stocks in this comparison pay dividends.
BXP, Inc. (BXP) offers the highest yield at 6. 9%, versus 1. 3% for Welltower Inc. (WELL).
09Is BXP or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +230. 2% 10Y return). Both have compounded well over 10 years (WELL: +230. 2%, BXP: -27. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BXP and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BXP is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.